Amir Samimi/LinkedIn
Oct 7, 2026, 15:28
Amir Samimi: Prognostic Value of Platelet Count in Resected HNSCC
Amir Samimi, Project Engineer at Pars Behin Palayesh Naft Qeshm, shared a post on LinkedIn about a recent article by Seyed Taher Mousavi and his colleague, published in Zenodo, adding:
“Platelet Count as a Prognostic Marker for Local Recurrence in Surgically Resectable Head and Neck Squamous Cell Carcinoma:
A Pathological Analysis
Pages 92-100.”
Title: Platelet Count as a Prognostic Marker for Local Recurrence in Surgically Resectable Head and Neck Squamous Cell Carcinoma: A Pathological Analysis
Authors: Seyed Taher Mousavi, Tala Pourlak

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 10:32Ibrahim Gwarzo: Identifying Care Gaps and Emergency Pain Delays in Sickle Cell Disease at APHA 2026
-
Nov 15, 2026, 10:17Ify Osunkwo: How the Sickle Cell Community Can Influence FDA Drug Development Priorities
-
Nov 15, 2026, 10:11Ahmed Abdelsalam: Why Matching ABO and RhD Groups Does Not Guarantee Crossmatch Compatibility
-
Nov 15, 2026, 10:06Asma Khalil: New British Society for Haematology Guidance on Paediatric and Neonatal Transfusion
-
Nov 15, 2026, 09:41Girishkumar Modi: Navigating the 2026 Jehovah’s Witness Transfusion Policy Shift in Clinical Practice
-
Nov 15, 2026, 04:31Aakriti Gupta: Anticoagulation for Leaflet Thickening After TAVR
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis